Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23810881 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
Condition: Heart Failure
Intervention: Drug: Eplerenone
2 Not yet recruiting Eplerenone in Heart Failure Treatment
Conditions: Heart Failure;   Acute Myocardial Infarction;   Hypertension
Intervention:

Indicates status has not been verified in more than two years